First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody–Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer

por Kim, Sung-Bae, Meric-Bernstam, Funda, Kalyan, Aparna, Babich, Aleksei, Liu, Rong, Tanigawa, Takahiko, Sommer, Anette, Osada, Motonobu, Reetz, Frank, Laurent, Dirk, Wittemer-Rump, Sabine, Berlin, Jordan
Publicado 2019